Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 3;10(1):1713.
doi: 10.1038/s41598-020-58688-y.

A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation

Affiliations

A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation

Patricia P Reis et al. Sci Rep. .

Abstract

Prognostic biomarkers for recurrence of Oral Squamous Cell Carcinoma (OSCC) are urgently needed. We aimed to independently validate a 4-gene expression signature (MMP1, COL4A1, P4HA2, THBS2) predictive of OSCC recurrence risk. Gene expression was measured using Nanostring nCounter® in 245 histologically normal surgical resection margins from 62 patients. Association between risk scores for individual patients and recurrence was assessed by Kaplan-Meier analysis. Signature performance was quantified by concordance index (CI), hazard ratio (HR) and the area under receiver operating characteristics (AUC). Risk scores for recurrence were significantly higher than recurrence-free patients (p = 9.58e-7, Welch's t-test). A solid performance of the 4-gene signature was determined: CI = 0.64, HR = 3.38 (p = 1.4E-4; log-rank test), AUC = 0.71. We showed that three margins per patient are sufficient to preserve predictive performance (CI = 0.65; HR = 2.92; p = 2.94e-3; AUC = 0.71). Association between the predicted risk scores and recurrence was assessed and showed HR = 2.44 (p = 9.6E-3; log-rank test, N = 62). Signature performance analysis was repeated using an optimized threshold (70th percentile of risks), resulting in HR = 3.38 (p = 1.4E-4; log-rank test, N = 62). The 4-gene signature was validated as predictive of recurrence risk in an independent cohort of patients with resected OSCC and histologically negative margins, and is potentially applicable for clinical decision making on adjuvant treatment and disease monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Boxplot depicting distribution of risks derived from margins samples of patients without (n = 28; 45%) and with locally recurrent tumors (n = 34; 55%).
Figure 2
Figure 2
Receiver operating characteristics depicting patient classification performance of the signature. Horizontal and vertical lines indicate sensitivity and false positive rate (1 – specificity) achieved when using median risk as the threshold. Associated statistics, including area under the curve and accuracy, are listed in the bottom right corner.
Figure 3
Figure 3
Kaplan-Meier plot depicting survival of the patients with low risk (LR) and high risk (HR) as estimated by applying the signature, stratifying patients using the median of the obtained risks (A) and optimized threshold, equal to 70th percentile of the obtained risks. (B) Colour-shaded areas depict 95% confidence intervals of the survival curves. Obtained statistics are listed in the bottom left corner.
Figure 4
Figure 4
Violin plots depicting distributions of the major indicators of the signature performance, including concordance index (CI), area under ROC (AUC) and hazard ratio (HR), obtained using one, two and three randomly chosen samples per patient to assess patient risk. Annotations show minimum, 2.5th percentile, median, 97.5th percentile and maximum of the given distributions.

References

    1. Petersen PE. Oral cancer prevention and control - The approach of the World Health Organization. Oral Oncol. 2009;45:454–460. doi: 10.1016/j.oraloncology.2008.05.023. - DOI - PubMed
    1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Anderson CR, Sisson K, Moncrieff M. A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma. Oral Oncol. 2015;51:464–469. doi: 10.1016/j.oraloncology.2015.01.015. - DOI - PubMed
    1. Feller L, Lemmer J. Oral Squamous Cell Carcinoma: Epidemiology, Clinical Presentation and Treatment. J. Cancer Ther. 2012;03:263–268. doi: 10.4236/jct.2012.34037. - DOI
    1. Weijers M, Snow GB, Bezemer PD, Van Der Waal I. The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma with regard to local recurrence; an analysis of 37 patients. J Oral Pathol Med. 2002;37:11–15. doi: 10.1034/j.1600-0714.2002.310103.x. - DOI - PubMed

Publication types